CLEC12A (C-type lectin domain family 12 member A)

2007-12-01  

Identity

HGNC
LOCATION
12p13.31
LOCUSID
ALIAS
CD371,CLL-1,CLL1,DCAL-2,MICL

Other Information

Locus ID:

NCBI: 160364
MIM: 612088
HGNC: 31713
Ensembl: ENSG00000172322

Variants:

dbSNP: 160364
ClinVar: 160364
TCGA: ENSG00000172322
COSMIC: CLEC12A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000172322ENST00000304361Q5QGZ9
ENSG00000172322ENST00000350667Q5QGZ9
ENSG00000172322ENST00000355690Q5QGZ9
ENSG00000172322ENST00000396507A8MVL9
ENSG00000172322ENST00000434319Q5QGZ9

Expression (GTEx)

0
5
10
15
20
25
30
35

Pathways

PathwaySourceExternal ID
Immune SystemREACTOMER-HSA-168256
Innate Immune SystemREACTOMER-HSA-168249
Neutrophil degranulationREACTOMER-HSA-6798695

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
383676672024Mechanistic insights into the C-type lectin receptor CLEC12A-mediated immune recognition of monosodium urate crystal.0
383865112024Crystal structure of the complex of CLEC12A and an antibody that interferes with binding of diverse ligands.0
383676672024Mechanistic insights into the C-type lectin receptor CLEC12A-mediated immune recognition of monosodium urate crystal.0
383865112024Crystal structure of the complex of CLEC12A and an antibody that interferes with binding of diverse ligands.0
365429802023Mycobacterial mycolic acids trigger inhibitory receptor Clec12A to suppress host immune responses.3
369280772023Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients.1
371026432023Behçet syndrome: The disturbed balance between anti- (CLEC12A, CLC) and proinflammatory (IFI27) gene expressions.1
365429802023Mycobacterial mycolic acids trigger inhibitory receptor Clec12A to suppress host immune responses.3
369280772023Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients.1
371026432023Behçet syndrome: The disturbed balance between anti- (CLEC12A, CLC) and proinflammatory (IFI27) gene expressions.1
354818142022CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia.1
354818142022CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia.1
330943192021CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy.36
330959152021Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression.0
333690702021Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.6

Citation

Dessen P

CLEC12A (C-type lectin domain family 12 member A)

Atlas Genet Cytogenet Oncol Haematol. 2007-12-01

Online version: http://atlasgeneticsoncology.org/gene/49855/clec12a